Sukrti Nagpal

TL;DR: Evaluating rotavirus vaccines approved for use (RV1, RV5, and LLR) for preventingRotavirus diarrhoea in children with high-mortality rates found that RV1 probably prevents 40% of severe all-cause diarrhoeA episodes, and RV5probably prevents 40%, based on one large multicentre trial in Latin America and Finland.

TL;DR: Assessment of the effects of oral nutritional supplements in people being treated with antituberculous drug therapy for active tuberculosis found Supplementation probably produces a modest increase in weight gain during treatment foractive tuberculosis, although this was not seen consistently across all trials.

TL;DR: Home- or community-based interventions which provide antimalarial drugs free of charge probably improve prompt access to antimalarials, and there is moderate quality evidence from rural Ethiopia that they may impact on childhood mortality when implemented in appropriate settings.

TL;DR: Evaluating rotavirus vaccines prequalified by the WHO (RV1, RV5, and Rotavac) for their efficacy and safety in children compared to placebo or no intervention found no increased risk of serious adverse events.

TL;DR: This article evaluated the effects of home-and community-based management strategies for treating malaria in sub-Saharan Africa and found that these strategies may increase the number of people with fever who receive an appropriate antimalarial within 24 hours.